6533b82ffe1ef96bd1295a0d
RESEARCH PRODUCT
Benefits of tiotropium/olodaterol compared with tiotropium in patients receiving COPD LAMA at baseline: pooled analysis of 4 clinical trials
Gary T. FergusonDave SinghFlorian VoßRoland BuhlA. De La Hozsubject
medicine.medical_specialtyCOPDbiologybusiness.industryTiotropium-olodaterolLamabiology.organism_classificationmedicine.diseaseClinical trialPooled analysisInternal medicinemedicineIn patientbusinessBaseline (configuration management)year | journal | country | edition | language |
---|---|---|---|---|
2020-02-28 | 61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V. |